Scientific Registry of Transplant Recipients

Scientific Registry of Transplant Recipients
Name	Scientific Registry of Transplant Recipients
Formation	1980s
Type	Nonprofit data registry
Headquarters	Chicago, Illinois
Region served	United States
Leader title	Director
Affiliations	United Network for Organ Sharing, Health Resources and Services Administration

Scientific Registry of Transplant Recipients is a United States-based clinical data registry that collects, analyzes, and reports outcomes for organ transplantation. It operates within a network of healthcare institutions and regulatory entities to support policy, practice, and patient decision-making through outcome measurement and risk-adjusted analyses. The registry interacts with multiple stakeholders including transplant centers, professional societies, federal agencies, patient advocacy organizations, and academic research centers.

History

The registry traces its origins to data initiatives that followed landmark events such as the National Organ Transplant Act and institutional responses modeled after registries like the Surveillance, Epidemiology, and End Results Program, United Network for Organ Sharing, and state-level reporting systems. Early collaborators included academic centers such as Massachusetts General Hospital, Mayo Clinic, and Johns Hopkins Hospital, alongside federal agencies including the Health Resources and Services Administration and regulatory bodies like the Centers for Medicare & Medicaid Services. Over time, the registry expanded methodologies influenced by analytic standards from organizations such as National Institutes of Health, Centers for Disease Control and Prevention, and international counterparts like NHS Blood and Transplant. High-profile clinical developments—such as advances at institutions like Cleveland Clinic, Mount Sinai Health System, and Stanford Health Care—shaped the registry’s scope and the community’s expectations for outcome transparency.

Governance and Funding

Governance involves oversight from advisory groups and boards that include representatives from entities such as United Network for Organ Sharing, American Society of Transplantation, American Society of Transplant Surgeons, and patient advocacy organizations tied to institutions like American Red Cross and disease-specific foundations such as American Heart Association and Cystic Fibrosis Foundation. Funding streams historically have included federal grants from agencies like Health Resources and Services Administration and contracts with academic institutions such as University of Chicago and Columbia University, as well as cooperative arrangements with stakeholders including Veterans Health Administration and state health departments. The registry’s governance structure resembles models employed by Institute of Medicine committees and nonprofit boards like those of Kaiser Permanente and Robert Wood Johnson Foundation.

Data Collection and Methodology

Data collection protocols align with clinical reporting standards used by transplant centers associated with hospitals such as Brigham and Women’s Hospital, UCLA Medical Center, and Presbyterian Hospital (New York) and leverage coding frameworks paralleling those from Centers for Disease Control and Prevention surveillance and National Cancer Institute data dictionaries. Methodologies incorporate risk adjustment techniques informed by statistical practices from academic groups at Harvard Medical School, University of Pennsylvania, and Johns Hopkins Bloomberg School of Public Health, and draw on outcomes research traditions seen in publications from The Lancet, New England Journal of Medicine, and JAMA. Case-level variables include donor factors linked to organizations like United Network for Organ Sharing and recipient variables routinely collected across transplant programs at centers such as Northwestern Memorial Hospital, Duke University Hospital, and University of Michigan Hospitals and Health Centers.

Public Reporting and Performance Metrics

Public reports present center-specific and organ-specific outcomes using benchmarks and metrics comparable to those used by Centers for Medicare & Medicaid Services, professional registries like Society of Thoracic Surgeons, and performance measurement frameworks from National Quality Forum. The registry’s reports have been cited in policymaking discussions involving stakeholders such as Department of Health and Human Services, patient groups including American Kidney Fund, and hospital systems like NewYork-Presbyterian Hospital. Reporting formats and risk-adjusted survival curves are analogous to those published by international bodies such as Transplantation Society and national systems including NHS Blood and Transplant.

Research and Quality Improvement Uses

Researchers at institutions such as Yale School of Medicine, University of California San Francisco, and University of Pittsburgh Medical Center use registry data for observational studies, comparative effectiveness research, and prognostic modeling appearing in journals like Annals of Internal Medicine and American Journal of Transplantation. Quality improvement collaboratives drawing on registry outputs have included initiatives at centers such as Houston Methodist Hospital and networks similar to Collaborative Quality Improvement Program models seen in Society of Critical Care Medicine. Registry-derived evidence has influenced practice guidelines promulgated by organizations such as American College of Surgeons, American Society of Nephrology, and specialty societies including International Society for Heart and Lung Transplantation.

Privacy, Ethics, and Data Access

Privacy protections and ethical oversight align with regulatory frameworks from agencies like Office for Civil Rights, ethical guidance resembling reports from Belmont Report-influenced committees, and data stewardship practices used by academic medical centers such as University of California systems. Data access protocols balance research use by investigators at universities such as Cornell University and nonprofit organizations with protections required by federal statutes and oversight bodies including Food and Drug Administration and Institutional Review Board processes at hospitals like Beth Israel Deaconess Medical Center.

Impact and Criticism

The registry has been credited with improving transparency and informing regulatory actions by entities such as Centers for Medicare & Medicaid Services and advocacy by groups like American Liver Foundation, while critics from academic centers including disputes echoing debates involving Duke University and policy commentators affiliated with think tanks such as The Brookings Institution have raised concerns about risk adjustment, unintended consequences for patient selection, and center benchmarking. Debates have referenced methodological critiques comparable to those raised in analyses from New England Journal of Medicine and policy discussions involving Health Affairs.

Category:Transplantation